These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37641532)

  • 41. Optimal designs for testing hypothesis in multiarm clinical trials.
    Baldi Antognini A; Novelli M; Zagoraiou M
    Stat Methods Med Res; 2019; 28(10-11):3242-3259. PubMed ID: 30232928
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Empirical efficiency maximization: improved locally efficient covariate adjustment in randomized experiments and survival analysis.
    Rubin DB; van der Laan MJ
    Int J Biostat; 2008; 4(1):Article 5. PubMed ID: 19381345
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Estimation of treatment effects based on possibly misspecified Cox regression.
    Hattori S; Henmi M
    Lifetime Data Anal; 2012 Oct; 18(4):408-33. PubMed ID: 22527680
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preserving the allocation ratio at every allocation with biased coin randomization and minimization in studies with unequal allocation.
    Kuznetsova OM; Tymofyeyev Y
    Stat Med; 2012 Apr; 31(8):701-23. PubMed ID: 22161821
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Locally efficient estimation of the quality-adjusted lifetime distribution with right-censored data and covariates.
    van der Laan MJ; Hubbard A
    Biometrics; 1999 Jun; 55(2):530-6. PubMed ID: 11318210
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Minimal sufficient balance-a new strategy to balance baseline covariates and preserve randomness of treatment allocation.
    Zhao W; Hill MD; Palesch Y
    Stat Methods Med Res; 2015 Dec; 24(6):989-1002. PubMed ID: 22287602
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Optimal allocation to treatment sequences in individually randomized stepped-wedge designs with attrition.
    Moerbeek M
    Clin Trials; 2023 Jun; 20(3):242-251. PubMed ID: 36825509
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Robustness of ANCOVA in randomized trials with unequal randomization.
    Bartlett JW
    Biometrics; 2020 Sep; 76(3):1036-1038. PubMed ID: 31823345
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Restricted mean survival time: Does covariate adjustment improve precision in randomized clinical trials?
    Karrison T; Kocherginsky M
    Clin Trials; 2018 Apr; 15(2):178-188. PubMed ID: 29502444
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Propensity score matching in randomized clinical trials.
    Xu Z; Kalbfleisch JD
    Biometrics; 2010 Sep; 66(3):813-23. PubMed ID: 19995353
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A simulation study for comparing testing statistics in response-adaptive randomization.
    Gu X; Lee JJ
    BMC Med Res Methodol; 2010 Jun; 10():48. PubMed ID: 20525382
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adjustment for Baseline Covariates to Increase Efficiency in RCTs with Binary Endpoint: A Comparison of Bayesian and Frequentist Approaches.
    Berchialla P; Sciannameo V; Urru S; Lanera C; Azzolina D; Gregori D; Baldi I
    Int J Environ Res Public Health; 2021 Jul; 18(15):. PubMed ID: 34360051
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Estimation in semiparametric transition measurement error models for longitudinal data.
    Pan W; Zeng D; Lin X
    Biometrics; 2009 Sep; 65(3):728-36. PubMed ID: 19173696
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Testing for treatment effect in covariate-adaptive randomized trials with generalized linear models and omitted covariates.
    Li Y; Ma W; Qin Y; Hu F
    Stat Methods Med Res; 2021 Sep; 30(9):2148-2164. PubMed ID: 33899607
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Variance reduction in randomised trials by inverse probability weighting using the propensity score.
    Williamson EJ; Forbes A; White IR
    Stat Med; 2014 Feb; 33(5):721-37. PubMed ID: 24114884
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A simulation study of the validity and efficiency of design-adaptive allocation to two groups in the regression situation.
    Aickin M
    Int J Biostat; 2009 May; 5(1):Article 19. PubMed ID: 20224630
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The optimal pre-post allocation for randomized clinical trials.
    Ma S; Wang T
    BMC Med Res Methodol; 2023 Mar; 23(1):72. PubMed ID: 36978004
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Doubly robust inference for targeted minimum loss-based estimation in randomized trials with missing outcome data.
    Díaz I; van der Laan MJ
    Stat Med; 2017 Oct; 36(24):3807-3819. PubMed ID: 28744883
    [TBL] [Abstract][Full Text] [Related]  

  • 59. ON ESTIMATION OF THE OPTIMAL TREATMENT REGIME WITH THE ADDITIVE HAZARDS MODEL.
    Kang S; Lu W; Zhang J
    Stat Sin; 2018 Jul; 28(3):1539-1560. PubMed ID: 30135619
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Improving efficiency of inference in clinical trials with external control data.
    Li X; Miao W; Lu F; Zhou XH
    Biometrics; 2023 Mar; 79(1):394-403. PubMed ID: 34694626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.